Akebia Therapeutics, Inc. (AKBA) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	8-K	10-Q	10-K	10-Q	10-Q	10-K	10-Q	10-Q
Assets
Current assets:
Cash and cash equivalents		57.0	90.5	143.9	174.6	149.8	207.2	247.0
Inventory		20.6	21.8	36.3	39.4	38.2	33.7	37.9
Accounts receivable, net		17.8	39.2	81.9	64.6	50.9	49.7	35.0
Prepaid expenses and other current assets		25.4	33.5	42.1	24.1	33.1	39.5	11.2
Total current assets		120.7	184.9	304.2	302.7	272.0	330.1	331.1
Property and equipment, net		4.8	5.2	6.0	6.5	6.8	7.2	7.7
Operating lease assets		28.0	29.2	31.5	32.6	33.9	23.2	24.4
Goodwill		55.1	55.1	55.1	55.1	55.1	55.1	55.1

Other intangible assets, net
Other assets		5.2	5.4	35.0	39.4	49.8	69.6	67.5
Total assets		276.9	351.8	521.8	535.4	525.6	602.3	611.9

Liabilities and stockholders' equity
Current liabilities:
Accounts payable		12.6	18.0	24.9	19.5	33.6	28.8	42.0
Accrued expenses and other current liabilities		46.4	71.0	91.3	109.7	104.5	144.7	111.7
Short-term deferred revenue			3.7	5.0	10.4	20.9	15.7	11.9
Current portion of long-term debt		24.0	32.0	98.2	97.8	97.5
Total current liabilities		82.9	124.8	233.7	253.9	256.5	189.2	165.6
Deferred revenue, net of current portion		43.3	43.3	43.3	65.4	21.5	28.0	16.6
Operating lease liabilities, net of current portion		27.4	29.0	31.7	32.6	33.7	20.3	21.7
Derivative liability		0.8	0.8	1.1	1.1	1.8	1.9	1.9
Long-term debt, net		26.3	34.1				97.2	96.9
Liability related to sale of future royalties		57.1
Refund liability to customer		40.8	41.0
Other non-current liabilities		12.6	12.2	66.9	77.7	82.5	77.4	85.4
Total liabilities		291.2	342.5	459.5	509.2	449.1	465.1	437.2

Commitments and contingencies (Note 12)
Stockholders' (deficit) equity:
Preferred stock $0.00001 par value, 25,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2023 and December 31, 2022
Common stock $0.00001 par value; 350		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital		1,564.8	1,562.2	1,555.8	1,548.9	1,536.8	1,526.8	1,504.8
Accumulated other comprehensive gain		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accumulated deficit		-1,579.1	-1,552.9	-1,493.5	-1,522.8	-1,460.4	-1,389.7	-1,330.1
Total stockholders' (deficit) equity		-14.4	9.3	62.3	26.1	76.5	137.2	174.6
Total liabilities and stockholders' (deficit) equity		276.9	351.8	521.8	535.4	525.6	602.3	611.9